Big Biotechs Have Short Sellers Confused
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
It is not a new scenario where an illness or problem starts to become a big deal in the public and there is a small-cap company that “has a solution for that” which happen…
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye disease.
A global coronavirus pandemic could kill more than 15 million people worldwide in just one year and cause more than $2 trillion in lost economic growth.
Consumer sentiment on Wednesday stopped a tumble that began in mid-February. Thursday's stock market action could send the Morning Consult index lower again, however, as volatility continues to rule the day.
Shares of Amarin have plunged in recent months. Even more troubling, there appears to no catalyst to drive them higher.
More and more companies are joining the fight against the coronavirus. Quest Diagnostics is one of the newest to make this list.
While business leaders remain optimistic about economic prospects this year, the spread of the coronavirus is beginning to tamp down enthusiasm.
Arcturus Therapeutics stock jumped on Wednesday after the company announced that it would be joining the fight against the latest coronavirus.
Ranging from very conservative to aggressive, these Raymond James health care stock picks are good additions to long-term portfolios looking to add or increase exposure to the sector.
Peanut allergy is a serious and dangerous, but one biotech may hold the answer that could lead to to a 100% or 200% gain as its peanut allergy drug is expected to become more…
Stealth Bio stock more than doubled on Tuesday after the company announced a critical update from the FDA.
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.
Tilray released fourth-quarter financial results after the closing bell on Monday. The company said that it had a net loss of $0.62 per share and $46.94 million in revenue, compared with consensus estimates that…